Background Hepatic resection and radiofrequency ablation (RFA) are treatment options for
early-stage hepatocellular carcinoma (HCC). Whether tumour recurrence and long-term …

Abstract Background and Aim Radiofrequency ablation (RFA) and percutaneous ethanol
injection (PEI) have been used for patients with hepatocellular carcinomas (HCCs)< 3 cm …

Background The therapeutic value of repeat hepatic resection (rHR) or radiofrequency
ablation (RFA) for recurrent hepatocellular carcinoma (HCC) is unknown. This study aimed …

Hypothesis Radiofrequency ablation is a safe and effective treatment for hepatocellular
carcinomas 3.1 to 8.0 cm in diameter. Design Case series with prospective data collection …

Among locoregional treatments for hepatocellular carcinoma (HCC), radiofrequency
ablation (RFA) has been accepted as the most popular alternative to curative transplantation …

Background The purpose of this investigation was to compare the outcome of percutaneous
radiofrequency thermal ablation therapy (PRFA) with surgical resection (SR) in the treatment …

Background In the present study we classified the radicality of percutaneous radiofrequency
thermal ablation (RFA) therapy according to the extent of the ablated margin. We measured …

Methods: PubMed, EMBASE, and Cochrane Library databases were used to identify all
randomized controlled trials comparing the survival between small HCC patients receiving …

Background Hepatocellular carcinoma (HCC) has a high worldwide prevalence and
mortality. While surgical resection and transplantation offers curative potential, donor …

Aim: We surveyed multiple centers to identify types and frequency of complications and
mortality rate associated with radiofrequency ablation (RFA) of hepatocellular carcinoma …